RESUMO
Background and Aim: Infectious bovine keratoconjunctivitis is the most crucial ophthalmic disease among ruminants worldwide. Moraxella is the bacteria generally associated with this disease and leads to keratitis, conjunctivitis, corneal ulcers, or blindness. Platelet-rich plasma (PRP) effects in corneal ulcers and different ocular superficial diseases in animals and humans are beneficial and enhance rapid healing and improvement, but the effects in infectious keratoconjunctivitis in ruminants are uncertain. This study aimed to examine the effect of PRP on re-epithelization, corneal tissue, clinical signs, and matrix metalloproteinase (MMP) expression in sheep with infectious keratoconjunctivitis. Materials and Methods: Eighteen sheep were divided into three groups and subjected to a disease-induction experiment. Group 1 (G1) was administered 1.0 mL PRP subconjunctivally, Group 2 (G2) was administered 1.0 mL PRP subconjunctivally and 50 µL gentamicin drops, and the control group (CG) was administered 50 µL saline solution topically every 12 h. Clinical ophthalmologic examination, fluorescein staining, and photography were carried out. Ulcerated areas were measured employing J-Image software. Five and eleven days following the procedure, half of the animals from each group were euthanized, and their corneas were evaluated by histopathology and zymography. Results: Control Group and G2 epithelialized more rapidly. The CG exhibited fewer clinical signs of ocular disease. In histopathological analysis, in G2, alterations were observed only in the epithelium. The CG and G1 exhibited alterations in the epithelium, stroma, and Descemet's membrane. In zymography, a decline in MMP-2 expression in the animals treated with PRP was detected. Matrix metalloproteinase-9 was significantly expressed in the animals treated with PRP monotherapy, whereas PRP + gentamicin and CG caused a decrease. Conclusion: Platelet-rich plasma alone did not demonstrate any beneficial effect on re-epithelialization, a decline in clinical signs, tissue alterations, and expression of metalloproteinases. Platelet-rich plasma combined with gentamicin was capable of suppressing MMPs, primarily MMP-9, but do not display positive effects in re-epithelization, reduction of clinical signs, or tissue effects. These outcomes are similar to those discovered in untreated animals, so the use of PRP in patients with infectious keratoconjunctivitis does not offer greater benefits in sheep. Additional research is required to validate the results of PRP use in natural disease presentation.
RESUMO
ABSTRACT: To determine the association between ocular abnormalities and hematologic findings in Ehrlichia canis-infected dogs, 120 dogs suspected of canine ehrlichiosis were studied. All patients were subjected to rapid serologic diagnostic test for Ehrlichia canis, and the diagnosis was confirmed by quantitative PCR. PCR-positive patients underwent ophthalmologic examination and a hemogram and were grouped into patients with thrombocytopenia and anemia (G1), patients with thrombocytopenia (G2), and patients without hematologic disorders (G3). For ophthalmic evaluation, the patients were grouped into those having mild, severe, both mild and severe, and no ocular alterations. All patients presented with uveitis (100%). Severe ocular disorders predominated in G1 and G2 patients. Dogs with anemia and leukopenia showed severe ocular disorders. In dogs with a greater number of leukocytes and copies/µl of the TRAG gene, the intraocular pressure (IOP) tends to decrease and vice versa (r = −0.23, r = −0.26). In conclusion, uveitis is the earliest ocular alteration of canine ehrlichiosis. The severity of ocular abnormalities in patients with ehrlichiosis is associated with thrombocytopenia and may be aggravated by anemia and leukopenia. The hemogram and IOP are useful tools for predicting eye involvement in Ehrlichia canis-infected patients. In regions where Ehrlichia canis is endemic, the use of the tonometer should be routinely in dog general consultation.
RESUMO: Para determinar a associação entre anormalidades oculares e achados hematológicos em cães infectados com Ehrlichia canis, foram estudados 120 cães com suspeita de erliquiose canina. Todos os pacientes foram submetidos a um teste diagnóstico sorológico rápido para Ehrlichia canis, e o diagnóstico foi confirmado por PCR quantitativa. Os pacientes com PCR positivo foram submetidos a exame oftalmológico e hemograma completo e foram agrupados em pacientes com trombocitopenia e anemia (G1), pacientes com trombocitopenia (G2) e pacientes sem distúrbios hematológicos (G3). Para avaliação oftalmológica, os pacientes foram agrupados em pacientes com alterações leves ou graves, leves e graves e sem anormalidades oculares. Todos os pacientes apresentaram uveíte (100%). Os distúrbios oculares graves predominaram nos pacientes do G1 e G2. Cães com anemia e leucopenia apresentaram distúrbios oculares graves. Em cães com maior número de leucócitos e cópias/µl do gene TRAG, a pressão intra-ocular tendeu a diminuir e vice-versa (r = -0.23, r = -0.26). Em conclusão, a uveíte é o primeiro distúrbio ocular da erliquiose canina. A gravidade das anormalidades oculares em pacientes com erliquiose está associada à trombocitopenia e pode ser agravada por anemia e leucopenia. Hemograma e PIO são ferramentas úteis para prever o envolvimento ocular em pacientes infectados com Ehrlichia canis. Nas regiões em que o Ehrlichia canis é endêmico, o uso do tonômetro deve ser rotineiro nas consultas gerais de cães.
